Caselmann, Wolfgang H.

Publishing since 1992 (Senior)

Has published 66 publications in 17 years

Number of publications published per year by Caselmann, Wolfgang H.. (Source : PubMed)

Distribution of publications types for Caselmann, Wolfgang H.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Gonzalez-Carmona MA, Lukacs-Kornek V, Timmerman A, Shabani S, Kornek M, Vogt A, Yildiz Y, Sievers E, Schmidt-Wolf IG, Caselmann WH, Sauerbruch T, Schmitz V. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.  Hepatology  2008;48;1  
•  Schmitz V, Raskopf E, Gonzalez-Carmona MA, Vogt A, Kornek M, Sauerbruch T, Caselmann WH. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.  Cancer Invest.  2008;26;5  
•  Schmitz V, Raskopf E, Gonzalez-Carmona MA, Vogt A, Rabe C, Leifeld L, Kornek M, Sauerbruch T, Caselmann WH. Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.  Gut  2007;56;2  
•  Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.  Digestion  2007;75;2-3  
•  Reisig V, Nennstiel-Ratzel U, Loss J, Eichhorn C, Caselmann WH, Wildner M. [Evidence and evaluation in health promotion and prevention: the example of the health promotion initiative "healthy living in Bavaria"]  Med. Klin. (Munich)  2006;101;12  
•  Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, Teschendorf C, Schmiegel W, Dührsen U, Halangk J, Iwan A, Sauerbruch T, Caselmann WH, Spengler U. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.  Clin. Cancer Res.  2006;12;15  
•  Schmitz V, Dombrowski F, Prieto J, Qian C, Diehl L, Knolle P, Sauerbruch T, Caselmann WH, Spengler U, Leifeld L. Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure.  Hepatology  2006;44;2  
•  Schmitz V, Vilanueva H, Raskopf E, Hilbert T, Barajas M, Dzienisowicz C, Gorschlüter M, Strehl J, Rabe C, Sauerbruch T, Prieto J, Caselmann WH, Qian C. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.  Gene Ther.  2006;13;16  
•  Gonzalez-Carmona MA, Schüssler S, Serwe M, Alt M, Ludwig J, Sproat BS, Steigerwald R, Hoffmann P, Quasdorff M, Schildgen O, Caselmann WH. Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells.  J. Hepatol.  2006;44;6  
•  Homann N, Stickel F, König IR, Jacobs A, Junghanns K, Benesova M, Schuppan D, Himsel S, Zuber-Jerger I, Hellerbrand C, Ludwig D, Caselmann WH, Seitz HK. Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers.  Int. J. Cancer  2006;118;8  

[ See timeline ] [ See all publications ]